Abstract
In this research, an ARFIMA model is proposed to forecast new COVID-19 cases in Algeria two weeks ahead. In the present study, public health database from Algeria health ministry has been used to build an ARFIMA model and used to forecast COVID-19 new cases in Algeria until May 11, 2020.
Background The aim of this study is first to find the best prediction method among the two techniques used and type of memory, either short or long, of the model constructed for the daily confirmed cases in Algeria, then make forecasts of the confirmed cases in the fifteen next days.
Methods This study was conducted based on daily new cases of COVID-19 that were collected from the official website of Algerian Ministry of Health from March 1, 2020 to April 26, 2020. Auto Regressive Integrated Moving Average (ARFIMA) model was used to predict the trend of confirmed cases. The evaluation of the fractional differentiation parameter (d) is carried out using OxMetrics 6 software.
Results The ARFIMA model (0, 0.431779, 0) build for Algeria, has a long memory and an upward trend over the next fifteen days and which coincides with the holy month of Ramadhan.
Conclusions The forecasted results obtained by the proposed ARFIMA model can be used as a decision support tool to manage medical efforts and facilities against the COVID-19 pandemic crisis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received, this research is only for academic use.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data were collected from the official website of Algerian Ministry of Health from March 1, 2020, to April 26, 2020. http://covid19.sante.gov.dz/carte/
https://fr.wikipedia.org/wiki/Pand%C3%A9mie_de_Covid-19_en_Alg%C3%A9rie
